Similar efficacy and safety of LY2963 016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin-naïve or previously treated with insulin glargine: A randomized, double-blind controlled trial (ELEMENT 2 study) - Rosenstock, J; Hollander, P; Bhargava, A (Diabetes Obes Metabol, 2015)
et al.